Filing Details
- Accession Number:
- 0001181431-12-030718
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-17 13:00:00
- Reporting Period:
- 2012-05-15
- Filing Date:
- 2012-05-17
- Accepted Time:
- 2012-05-17 17:10:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1459450 | Myrexis Inc. | MYRX | Pharmaceutical Preparations (2834) | 263996918 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1416041 | P. Gerald Belle | C/O Myrexis, Inc. 305 Chipeta Way Salt Lake City UT 84108 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-05-15 | 8,930 | $2.74 | 49,530 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2012-05-16 | 27,700 | $2.74 | 77,230 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The shares were purchased in multiple transactions at prices ranging from $2.73 to $2.74 per share. The price reported above is the weighted average purchase price. See footnote (3)
- The shares were purchased in multiple transactions at prices ranging from $2.73 to $2.74 per share. The price reported above is the weighted average purchase price. See footnote (3)
- The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth above.